Literature DB >> 12140464

Narrowband UVB phototherapy for early-stage mycosis fungoides.

Raechele Cochran Gathers1, Lubomira Scherschun, Farah Malick, David P Fivenson, Henry W Lim.   

Abstract

BACKGROUND: Narrowband UVB (NB-UVB) phototherapy has been shown to be effective for the treatment of various dermatoses.
OBJECTIVE: We evaluated the effect of NB-UVB in the treatment of early stage mycosis fungoides (MF).
METHODS: The response of 24 patients (12 stage IA, 12 stage IB) with patch stage MF to thrice weekly NB-UVB was assessed. Twelve patients had skin phototypes I-III, and 12 had types IV-VI. Seven patients had hypopigmented MF. Mean follow-up period was 29.0 weeks.
RESULTS: Thirteen patients (54.2%) had a complete response (CR), 7 (29.2%) had partial response (PR), and 4 (16.7%) had no response. Specimens from a repeat biopsy in 10 patients with CR showed histologic clearing in 9 of them. Upon discontinuation of treatment, 4 patients with CR relapsed, with a mean time to relapse of 12.5 weeks.
CONCLUSION: NB-UVB is a viable, comparably safe, and easily administered alternative in the management of early stage MF.

Entities:  

Mesh:

Year:  2002        PMID: 12140464     DOI: 10.1067/mjd.2002.120911

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  Comprehensive review of ultraviolet radiation and the current status on sunscreens.

Authors:  Brummitte Dale Wilson; Summer Moon; Frank Armstrong
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

Review 2.  The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

Authors:  Ercole Mazzeo; Laura Rubino; Michela Buglione; Paolo Antognoni; Stefano Maria Magrini; Francesco Bertoni; Manuela Parmiggiani; Paola Barbieri; Filippo Bertoni
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-13

3.  Need for Expansion of Coverage for Narrowband UVB Phototherapy in Mycosis Fungoides and Sézary Syndrome.

Authors:  Agnes Kim; Amelia Insley; Lindsey West; Heather Woodworth Goff
Journal:  Am Health Drug Benefits       Date:  2021-12

4.  Cutaneous T-cell lymphoma in sub-Saharan Africa.

Authors:  Matthew Ulrickson; Fred Okuku; Victoria Walusansa; Oliver Press; Sam Kalungi; David Wu; Fred Kambugu; Corey Casper; Jackson Orem
Journal:  J Natl Compr Canc Netw       Date:  2013-03-01       Impact factor: 11.908

Review 5.  Review of the treatment of mycosis fungoides and Sézary syndrome: A stage-based approach.

Authors:  Ghadah I Al Hothali
Journal:  Int J Health Sci (Qassim)       Date:  2013-06

Review 6.  Photoimmunology.

Authors:  Craig A Elmets; Cather M Cala; Hui Xu
Journal:  Dermatol Clin       Date:  2014-05-05       Impact factor: 3.478

7.  Radiosensitization of human breast cancer cells to ultraviolet light by 5-fluorouracil.

Authors:  Kazuhito Sasaki; Nelson H Tsuno; Eiji Sunami; Kazushige Kawai; Yasutaka Shuno; Kumiko Hongo; Masaya Hiyoshi; Manabu Kaneko; Koji Murono; Noriko Tada; Takako Nirei; Joji Kitayama; Koki Takahashi; Hirokazu Nagawa
Journal:  Oncol Lett       Date:  2011-03-01       Impact factor: 2.967

Review 8.  Current and emerging treatment strategies for cutaneous T-cell lymphoma.

Authors:  Frederick Lansigan; Francine M Foss
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

9.  Narrowband ultraviolet B phototherapy of early stage mycosis fungoides in korean patients.

Authors:  Min Soo Jang; Jae Woo Baek; Jong Bin Park; Dong Young Kang; Jin Seuk Kang; Kee Suck Suh; Sang Tae Kim
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

10.  Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Authors:  Alexandra C Hristov; Trilokraj Tejasvi; Ryan A Wilcox
Journal:  Am J Hematol       Date:  2021-08-02       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.